BioInvent International AB Year-End Report January 1 - December 31, 2022

LUND, SWEDEN / ACCESSWIRE / February 22, 2023 / BioInvent International (STO:BINV)"BioInvent made significant advances in 2022, further developing our exciting pipeline of novel and first-in-class immuno-modulatory antibodies for cancer therapy and …